Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.10 CNY
11.59 M CNY
1.20 B CNY
211.70 M
About NINGBO MENOVO PHARMACEUTICAL
Sector
CEO
Cheng Zhi Yao
Headquarters
Ningbo
Website
Founded
2004
ISIN
CNE100002Y25
FIGI
BBG007N8QN02
Ningbo Menovo Pharmaceutical Co., Ltd. engages in the research, development, production and sales of specialty APIs and pharmaceutical intermediates. The company provides sales of pharmaceutical raw materials and intermediates, chemical raw materials and products, research and development of pharmaceutical raw materials, preparations, hard capsules and intermediates, self-operated or agency import and export business of various commodities and technologies, but the state Exceptions include goods and technologies that are prohibited or restricted from operation. Its products include pharmaceutical intermediates, active pharmaceutical ingredients, medical formulations, and finished medicines. The company was founded by Cheng Zhi Yao on February 19, 2004 and is headquartered in Ningbo, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603538 is 13.40 CNY — it has decreased by −2.26% in the past 24 hours. Watch NINGBO MENOVO PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange NINGBO MENOVO PHARMACEUTICAL stocks are traded under the ticker 603538.
603538 stock has fallen by −4.63% compared to the previous week, the month change is a −3.53% fall, over the last year NINGBO MENOVO PHARMACEUTICAL has showed a −29.36% decrease.
We've gathered analysts' opinions on NINGBO MENOVO PHARMACEUTICAL future price: according to them, 603538 price has a max estimate of 15.26 CNY and a min estimate of 14.00 CNY. Watch 603538 chart and read a more detailed NINGBO MENOVO PHARMACEUTICAL stock forecast: see what analysts think of NINGBO MENOVO PHARMACEUTICAL and suggest that you do with its stocks.
603538 reached its all-time high on Mar 31, 2022 with the price of 62.05 CNY, and its all-time low was 9.66 CNY and was reached on Sep 11, 2018. View more price dynamics on 603538 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603538 stock is 3.07% volatile and has beta coefficient of 1.38. Track NINGBO MENOVO PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is NINGBO MENOVO PHARMACEUTICAL there?
Today NINGBO MENOVO PHARMACEUTICAL has the market capitalization of 2.91 B, it has decreased by −6.38% over the last week.
Yes, you can track NINGBO MENOVO PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
NINGBO MENOVO PHARMACEUTICAL is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
603538 net income for the last quarter is 44.31 M CNY, while the quarter before that showed 4.90 M CNY of net income which accounts for 804.39% change. Track more NINGBO MENOVO PHARMACEUTICAL financial stats to get the full picture.
Yes, 603538 dividends are paid annually. The last dividend per share was 0.02 CNY. As of today, Dividend Yield (TTM)% is 0.15%. Tracking NINGBO MENOVO PHARMACEUTICAL dividends might help you take more informed decisions.
NINGBO MENOVO PHARMACEUTICAL dividend yield was 0.10% in 2023, and payout ratio reached 36.63%. The year before the numbers were 0.64% and 10.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 23, 2024, the company has 2.35 K employees. See our rating of the largest employees — is NINGBO MENOVO PHARMACEUTICAL on this list?
Like other stocks, 603538 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NINGBO MENOVO PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NINGBO MENOVO PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NINGBO MENOVO PHARMACEUTICAL stock shows the sell signal. See more of NINGBO MENOVO PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.